Download PDF
Synlett 2022; 33(15): 1500-1504
DOI: 10.1055/a-1873-4473
letter

An Efficient Synthesis of a Highly Functionalized Dihydrobenzo­thiophene Derivative: A Ring-Contracted Analogue of the Anti-inflammatory Drug Propoxicam

Giammarco Tenti
,
José Clerigué
,
M. Teresa Ramos
,
J. Carlos Menéndez  ∗
Funding from Ministerio de Ciencia e Innovación (RTI2018-097662-B-I00) is gratefully acknowledged.
› Further Information
    Permissions and Reprints All articles of this category


Abstract

A five-step route to a ring-contracted analogue of the oxicam derivative propoxicam from thiosalicylic acid, sarcosine and N,N-dimethyl-1,3-propanediamine is described. The route has as key steps the base-promoted cross-Claisen coupling of protected sarcosine and thiosalicylic acid derivatives, the installation of a β-ketoamide moiety and a final Hg(II)-induced cyclization that creates the C–S bond of the benzothiophen-3-one core.

Key words

oxicam - benzotriazole activation - cross-Claisen coupling - β-ketoamide synthesis - benzothiophene synthesis - domino reactions

Supporting Information

    Supporting information for this article is available online at https://doi.org/10.1055/a-1873-4473.
  • Supporting Information


Publication History

Received: 13 April 2022

Accepted after revision: 10 June 2022

Accepted Manuscript online:
10 June 2022

Article published online:
08 July 2022

© 2022. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References and Notes

  • 1 Xu S, Rouzer CA, Marnett LJ. IUBMB Life 2014; 66: 803
    CrossrefPubMed
  • 2 Gouda MA, Hussein BH. M, El-Said Sherif Y. Synth. Commun. 2017; 47: 1709
    Crossref
  • 3 Lewandowska P, Szczuka I, Bednarz-Misa I, Szczęśniak-Sięga BM, Neubauer K, Mierzchała-Pasierb M, Zawadzki M, Witkiewicz W, Krzystek-Korpacka M. Molecules 2021; 26: 7375
    CrossrefPubMed
  • 4 Kaduševǐcius E. Int. J. Mol. Sci. 2021; 22: 6637
    CrossrefPubMed
  • 5 Majumdar A, Kundu D, Sarkar M. J. Phys. Chem. B 2015; 119: 9627
    CrossrefPubMed
  • 6 Nicolas C, Verny M, Giraud I, Ollier M, Rapp M, Maurizis J.-C, Madelmont J.-C. J. Med. Chem. 1999; 42: 5235-5240
    CrossrefPubMed
  • 7 2-((4-Methoxybenzyl)thio)benzoic Acid (4) A solution of 4-methoxy-α-toluenethiol (3) (170 mg, 1.1 mmol) in anhydrous THF (2 mL) was placed in a two-necked flask equipped with a condenser under an argon atmosphere. The flask was cooled in an ice bath prior to the dropwise addition of LDA (0.6 mL, 2 M solution in THF, 1.2 mmol). In another flask, 2-fluorobenzoic acid (2) (140 mg, 1 mmol) was dissolved in anhydrous THF (2 mL) under an argon atmosphere and, after cooling in an ice bath, LDA (0.6 mL, 2 M solution in THF, 1.2 mmol) was added dropwise. The two reactions were allowed to warm to room temperature and stirred for 30 min. After this time, the benzoic acid solution was added slowly to the two-necked flask, and the resulting reaction mixture was stirred at reflux for 16 h. The reaction was then cooled to room temperature, poured onto ice and the mixture was acidified with aqueous 2 M HCl solution. The solid obtained was washed with cold water and dried to afford 4 as a white solid (235 mg, 86%). 1H NMR (250 MHz, DMSO-d 6): δ = 7.87 (d, J = 7.3 Hz, 1 H), 7.47 (br s, 2 H), 7.34 (d, J = 8.6 Hz, 2 H), 7.24–7.15 (m, 1 H), 6.89 (d, J = 8.6 Hz, 2 H), 4.13 (s, 2 H), 3.73 (s, 3 H). 13C NMR (63 MHz, DMSO-d 6): δ = 167.47 (Cq), 158.45 (Cq), 141.55 (Cq), 132.37 (CH), 130.96 (CH), 130.38 (2 × CH), 128.21 (Cq), 127.59 (Cq), 125.71 (CH), 123.92 (CH), 113.93 (2 × CH), 55.10 (OCH3), 35.09 (CH2). These data correspond with those reported in the literature, see: Reference 17.
  • 8 (Benzo[d][1,2,3]triazol-1-yl)(2-((4-methoxybenzyl)thio)phenyl)methanone (5) SOCl2 (0.22 mL, 3 mmol) was added to a stirred solution of benzotriazole (0.953 g, 8 mmol) in anhydrous CH2Cl2 (25 mL). Stirring was continued for 30 min. Compound 4 (0.549 g, 2 mmol) was then added to the reaction mixture and stirring was continued for another 16 h. The resulting white precipitate was filtered off and washed with CH2Cl2. The combined filtrate was washed with 10% NaOH aqueous solution and brine, dried over MgSO4, and concentrated to give a pale yellow solid. Flash chromatography over silica gel, using n-hexane/ethyl acetate from 100:0 to 90:10, gave compound 5 (0.675 g, 90%) as an off-white powder. Mp 99–101 °C. IR (film): 2959, 2931, 2836, 1705, 1606, 1581, 1508, 1451, 1361 cm–1. 1H NMR (250 MHz, CDCl3): δ = 8.41 (d, J = 8.2 Hz, 1 H), 8.16 (d, J = 8.2 Hz, 1 H), 7.85–7.34 (m, 6 H), 7.11 (d, J = 8.7 Hz, 2 H), 6.74 (d, J = 8.7 Hz, 2 H), 4.04 (s, 2 H), 3.76 (s, 3 H). 13C NMR (63 MHz, CDCl3): δ = 167.18 (Cq), 158.92 (Cq), 146.24 (Cq), 136.56 (Cq), 135.23 (Cq), 132.05 (CH), 131.85 (CH), 131.68 (Cq), 130.57 (CH), 130.23 (2 × CH), 129.92 (CH), 128.50 (Cq), 126.55 (2 × CH), 120.33 (CH), 114.70 (CH), 113.96 (2 × CH), 55.31 (OCH3), 39.58 (CH2). Anal Calcd for C21H17N3O2S: C, 67.18; H, 4.56; N, 11.19; S, 8.54. Found: C, 66.81; H, 4.52; N, 11.20; S, 8.46.
  • 9 Methyl 2-((tert-Butoxycarbonyl)(methyl)amino)-3-(2-((4-methoxybenzyl)thio)phenyl)-3-oxopropanoate (7) Sodium hexamethyldisilazide (1.0 mL, 1 M solution in THF, 1 mmol) was slowly added to a cold (–20 °C) solution of N-Boc-sarcosine methyl ester 6 (0.102 g, 0.5 mmol) in anhydrous THF (2 mL) under an argon atmosphere. After stirring for 2 h, a solution of compound 5 (0.188 g, 0.5 mmol) in anhydrous THF (3 mL) was added. The reaction mixture was then allowed to warm to 0 °C and stirred for 16 h. After completion of the reaction (as monitored by TLC), a saturated solution of NH4Cl (10 mL) was added and the aqueous mixture was extracted with ethyl acetate. The combined extracts were dried and evaporated under reduced pressure. The crude mixture was purified by flash chromatography over silica gel, using a gradient of n-hexane/ethyl acetate from 100:0 to 80:20, to give 7 as a pale yellow solid (0.140 g, 61%), comprised of a mixture of the target β-ketoester and its tautomeric enol and carbamate rotamers, as reported below. Mp 104–106 °C. IR (film): 2960, 2920, 2850, 1751, 1680, 1608, 1583, 1509, 1436, 1377, 1322 cm–1. 1H NMR (250 MHz, CDCl3): δ = 12.30 and 12.14 (s, 1 H, enol), 7.88 (d, J = 7.9 Hz, 1 H, β-ketoester) and 7.71 (d, J = 8.1 Hz, 1 H, β-ketoester), 7.47–7.41 (m, 1 H, enol + β-ketoester), 7.36–7.14 (m, 5 H, enol + β-ketoester), 6.81 (t, J = 8.4 Hz, 2 H, enol + β-ketoester), 6.45 and 6.10 (s, 1 H, β-ketoester), 4.10 (s, 2 H, enol + β-ketoester), 3.84, 3.80, 3.78 and 3.77 (s, 6 H, enol + β-ketoester), 2.82, 2.79, 2.60 and 2.58 (s, 3 H, enol + β-ketoester), 1.45, 1.42 and 1.37 (s, 9 H, enol + β-ketoester). 13C NMR (63 MHz, CDCl3): δ = 194.50 (Cq), 193.78 (Cq), 172.04 (Cq), 171.62 (Cq), 170.35 (Cq), 168.82 (Cq), 168.38 (Cq), 159.03 (Cq), 158.96 (Cq), 155.82 (Cq), 155.65 (Cq), 154.49 (Cq), 143.04 (Cq), 135.19 (Cq), 134.79 (Cq), 134.30 (Cq), 133.67 (Cq), 133.12 (CH), 132.91 (CH), 132.26 (Cq), 131.11 (CH), 130.52 (CH), 130.34 (CH), 130.28 (CH), 130.25 (CH), 130.17 (CH), 130.09 (CH), 130.04 (CH), 129.09 (Cq), 128.85 (Cq), 128.69 (CH), 128.37 (CH), 128.00 (CH), 127.81 (Cq), 126.89 (CH), 126.08 (CH), 124.59 (CH), 124.25 (CH), 114.12 (CH), 113.99 (CH), 109.76 (Cq), 109.54 (Cq), 81.56 (Cq), 81.18 (Cq), 80.07 (Cq), 65.87 (OCH3), 63.81 (OCH3), 55.40 (OCH3), 55.37 (OCH3), 52.64 (OCH3), 52.57 (OCH3), 52.40 (OCH3), 52.17 (OCH3), 38.95 (CH2), 38.59 (CH2), 37.60 (CH2), 37.10 (CH2), 36.22 (CH3), 32.45 (CH3), 32.27 (CH3), 31.09 (CH3), 28.49 (CH3), 28.34 (CH3). HRMS (ESI-negative): m/z [M – H]– calcd for C24H28NO6S: 458.16428; found: 458.16287. Anal. Calcd for C24H29NO6S: C, 62.73; H, 6.36; N, 3.05; S, 6.98. Found: C, 62.73; H, 6.25; N, 3.17; S, 7.00.
  • 10 tert-Butyl (1-((3-(Dimethylamino)propyl)amino)-3-(2-((4-methoxybenzyl)thio)phenyl)-1,3-dioxopropan-2-yl)(methyl)carbamate (8) To a solution of compound 7 (460 mg, 1.0 mmol), N,N-dimethyl-1,3-propanediamine (102 mg, 1.0 mmol) and DMAP (18 mg, 0.15 mmol) in toluene (3 mL), placed in a sealed tube equipped with a stirring bar, were added 4 Å MS (100 mg) and the suspension was heated at 130 °C for 16 h. After completion, the reaction mixture was cooled to room temperature and the suspension was filtered through a short pad of Celite, which was thoroughly rinsed with toluene and ethyl acetate. The solvents were removed under reduced pressure and the crude mixture was purified by flash chromatography over silica gel, using dichloromethane/methanol from 100:0 to 90:10, to give 8 as a yellow solid (440 mg, 83%), comprised of a mixture of two different carbamate rotamers that are reported below. Mp 128–130 °C. IR (film): 3374, 2929, 2820, 2770, 1690, 1605, 1507, 1458, 1435, 1346 cm–1. 1H NMR (250 MHz, CDCl3): δ = 14.49 (s, 1 H), 8.08 (s, 1 H), 7.51–7.02 (m, 6 H), 6.79 (d, J = 8.7 Hz, 2 H), 4.11 and 4.07 (s, 2 H), 3.77 (s, 3 H), 3.52–3.34 (m, 2 H), 2.88, 2.60 and 2.59 (s, 3 H), 2.43 (t, J = 5.7 Hz, 2 H), 2.24, 2.20 and 2.17 (s, 6 H), 1.74–1.66 (m, 2 H), 1.44, 1.41 and 1.34 (s, 9 H). 13C NMR (63 MHz, CDCl3): δ = 170.34 (Cq), 168.20 (Cq), 158.90 (Cq), 155.16 (Cq), 135.39 (Cq), 135.19 (Cq), 130.64 (CH), 130.31 (CH), 130.22 (CH), 129.82 (CH), 129.62 (CH), 129.34 (Cq), 129.08 (Cq), 128.58 (CH), 128.09 (CH), 126.19 (CH), 126.09 (CH), 114.08 (CH), 113.95 (CH), 110.17 (Cq), 80.32 (Cq), 59.83 (CH2), 55.38 (CH3), 45.76 (CH3), 45.55 (CH3), 40.51 (CH2), 38.98 (CH2), 38.62 (CH2), 37.24 (CH3), 36.15 (CH3), 28.59 (CH3), 28.45 (CH3), 28.37 (CH3), 24.91 (CH2), 24.76 (CH2). HRMS (ESI-positive): m/z [M + H]+ calcd for C28H40N3O5S: 530.2683; found: 530.2476. Anal. Calcd for C28H39N3O5S: C, 63.49; H, 7.42; N, 7.93; S, 6.05. Found: C, 63.16; H, 7.23; N, 7.80; S, 5.93.
  • 11 3-(3-(2-((4-Methoxybenzyl)thio)phenyl)-2-(methylamino)-3-oxopropanamido)-N,N-dimethylpropan-1-ammonium Chloride (9) To a stirred solution of 8 (106 mg, 0.2 mmol) in AcOEt (2 mL) was added fuming SnCl4 (130 mg, 0.5 mmol) at room temperature. CAUTION! SnCl4 irritates the respiratory system. The resulting clear solution was stirred until TLC analysis indicated complete consumption of the starting material (2 h). The solvent was evaporated in vacuo and the crude residue was purified by flash chromatography over silica gel, using dichloromethane/methanol from 100:0 to 70:30, to give 9 as a pale yellow solid (55 mg, 58%). 1H NMR (250 MHz, DMSO-d 6): δ = 10.44 (s, 1 H), 9.82 (s, 1 H), 9.60 (s, 1 H), 8.37 (d, J = 7.7 Hz, 1 H), 7.61 (s, 2 H), 7.33 (d, J = 7.9 Hz, 3 H), 6.89 (d, J = 7.7 Hz, 2 H), 6.01 (s, 1 H), 4.19 (dd, J = 28.8, 12.4 Hz, 2 H), 3.73 (s, 3 H), 3.26–3.01 (m, 2 H), 2.92 (t, J = 7.6 Hz, 2 H), 2.65 (s, 6 H), 2.56 (s, 3 H), 1.90–1.65 (m, 2 H). 13C NMR (63 MHz, DMSO-d 6): δ = 188.85 (Cq), 161.76 (Cq), 158.50 (Cq), 142.95 (Cq), 134.04 (CH), 131.87 (CH), 130.40 (2 × CH), 129.61 (Cq), 127.80 (Cq), 126.71 (CH), 124.14 (CH), 113.98 (2 × CH), 66.58 (CH3), 55.13 (CH), 54.09 (CH2), 41.92 (CH3), 36.37 (CH2), 35.31 (CH2), 31.28 (CH3), 23.43 (CH2). Anal. Calcd for C23H32ClN3O3S: C, 59.28; H, 6.92; N, 9.02; S, 6.88. Found: C, 59.06; H, 7.13; N, 8.80; S, 6.63.
  • 12 4-Hydroxy-3-(methylamino)-2H-thiochromen-2-one (11) A solution of 8 (106 mg, 0.2 mmol), anisole (65 mg, 0.6 mmol) and trifluoroacetic acid (2 mL) was stirred at room temperature for 2 h. After completion of the reaction (as monitored by TLC), the pH was adjusted to 7 by employing an aqueous saturated solution of NaHCO3 and the aqueous solution was extracted with ethyl acetate (3 × 10 mL). The combined extracts were dried and evaporated under reduced pressure. The crude mixture was purified by flash chromatography over silica gel, eluting with dichloromethane/methanol from 100:0 to 95:5, to give compound 11 as an off-white solid (29 mg, 71%). Mp 227–229 °C. IR (film): 3017, 2787, 1567, 1538, 1480, 1434, 1378, 1312 cm–1. 1H NMR (250 MHz, DMSO-d 6): δ = 9.31 (s, 1 H), 8.19 (d, J = 7.9 Hz, 1 H), 7.63–7.21 (m, 3 H), 2.68 (s, 3 H). 13C NMR (63 MHz, DMSO-d 6): δ = 170.98 (Cq), 170.84 (Cq), 134.53 (Cq), 130.28 (CH), 129.95 (Cq), 127.65 (CH), 125.48 (CH), 125.25 (CH), 111.49 (Cq), 34.17 (CH3). HRMS (ESI-positive): m/z [M + H]+ calcd for C10H10NO2S: 208.0427; found, 208.0389.
  • 13 Nishimura O, Kitada C, Fujino M. Chem. Pharm. Bull. 1978; 26: 1576
    Crossref
  • 14 tert-Butyl (4-Hydroxy-2-oxo-2H-thiochromen-3-yl)(methyl)carbamate (12) A solution of compound 8 (104 mg, 0.2 mmol), mercury(II) trifluoroacetate (111 mg, 0.26 mmol) and aqueous acetic acid (80% by weight, 3 mL) was stirred at room temperature for 2 h and then 2-mercaptoethanol (31 mg, 0.4 mmol) was added. The resulting mixture was stirred for 2 h and then filtered through a pad of silica gel. The silica gel was rinsed with Et2O (3 × 15 mL) and then water (20 mL) was added to the filtrate. The organic layer was separated and washed with brine, dried over MgSO4, filtered and concentrated. The crude residue was purified by flash chromatography over silica gel, using dichloromethane/ethyl acetate from 100:0 to 90:10, to give compound 12 as a white solid (48 mg, 79%), comprised of a mixture of two carbamate rotamers. 1H NMR (250 MHz, MeOD): δ = 8.26 (d, J = 8.1 Hz, 1 H), 7.72–7.42 (m, 3 H), 3.03 and 2.99 (s, 3 H), 1.53 and 1.35 (s, 9 H). 13C NMR (63 MHz, MeOD): δ = 182.75 (Cq), 163.33 (Cq), 157.74 (Cq), 136.46 and 136.19 (Cq), 132.10 and 132.04 (CH), 128.29 and 128.23 (CH), 127.66 and 127.61 (CH), 126.50 (CH), 125.74 and 125.67 (Cq), 121.12 (Cq), 82.46 and 81.67 (Cq), 36.76 and 35.53 (CH3), 28.56 and 28.36 (CH3). Anal. Calcd for C15H17NO4S: C, 58.61; H, 5.57; N, 4.56; S, 10.43. Found: C, 58.38; H, 5.70; N, 4.57; S, 10.27.
  • 15 N-(3-(Dimethylamino)propyl)-2-(methylamino)-3-oxo-2,3-dihydrobenzo[b]thiophene-2-carboxamide (1) A solution of compound 8 (233 mg, 0.5 mmol), mercury(II) trifluoroacetate (320 mg, 0.75 mmol), anisole (162 mg, 1.5 mmol) and trifluoroacetic acid (0.75 mL) was stirred at 0 °C for 2 h. The trifluoroacetic acid solvent was removed in vacuo, whereupon MeOH (1.0 mL) and 2-mercaptoethanol (195 mg, 2.5 mmol) were added at 0 °C. The resulting mixture was stirred at the same temperature for 2 h and then the solvent was removed under reduced pressure. The crude mixture was purified by flash chromatography on silica gel, using dichloromethane/methanol/NH4OH from 100:0:0 to 92:7:1, to give 1 as a pale yellow syrup (110 mg, 72%). IR (neat): 3330, 2945, 2862, 1702, 1671, 1589, 1447 cm–1. 1H NMR (250 MHz, acetone-d 6): δ = 8.23 (s, 1 H), 7.83–7.57 (m, 2 H), 7.52 (dt, J = 7.8, 0.9 Hz, 1 H), 7.40–7.13 (m, 1 H), 3.34–3.17 (m, 3 H), 2.34–2.26 (m, 5 H), 2.01 (s, 6 H), 1.65–1.52 (m, 2 H). 13C NMR (63 MHz, acetone-d 6): δ = 199.23 (Cq), 166.84 (Cq), 153.26 (Cq), 137.42 (CH), 130.70 (Cq), 127.58 (CH), 125.77 (CH), 125.47 (CH), 88.63 (Cq), 59.00 (CH2), 45.28 (CH3), 40.48 (CH2), 30.42 (CH3), 26.19 (CH2). HRMS (ESI-positive): m/z [M + H]+ calcd for C15H22N3O2S: 308.14272; found: 308.14310. Anal. Calcd for C15H21N3O2S: C, 58.61; H, 6.89; N, 13.67; S, 10.43. Found: C, 58.31; H, 6.92; N, 13.62; S, 10.08.
  • 16 Davies AG. J. Chem. Res., Synop. 2001; 253
    Crossref
  • 17 Pinna G, Bellucci MC, Malpezzi L, Pisani L, Superchi S, Volonterio A, Zanda M. Tetrahedron 2011; 67: 5268
    Crossref